NCI, Inc. (NCIT) Tops Q4 EPS by 2c; Issues Light Q1, FY12 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts NCIT Hot Sheet
Join SI Premium – FREE
NCI, Inc. (NASDAQ: NCIT) reported Q4 EPS of $0.15, $0.02 better than the analyst estimate of $0.13. Revenue for the quarter came in at $114.8 million versus the consensus estimate of $116.8 million.
NCI, Inc. sees Q1 2012 EPS of $0.09-$0.11, versus the consensus of $0.13. NCI, Inc. sees Q1 2012 revenue of $92-$97 million, versus the consensus of $99.6 million.
NCI, Inc. sees FY2012 EPS of $0.20-$0.38, versus the consensus of $0.44. NCI, Inc. sees FY2012 revenue of $345-$375 million, versus the consensus of $348.8 million.
For earnings history and earnings-related data on NCI, Inc. (NCIT) click here.
NCI, Inc. sees Q1 2012 EPS of $0.09-$0.11, versus the consensus of $0.13. NCI, Inc. sees Q1 2012 revenue of $92-$97 million, versus the consensus of $99.6 million.
NCI, Inc. sees FY2012 EPS of $0.20-$0.38, versus the consensus of $0.44. NCI, Inc. sees FY2012 revenue of $345-$375 million, versus the consensus of $348.8 million.
For earnings history and earnings-related data on NCI, Inc. (NCIT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RXO shares soar as C.H. Robinson announces $5.8B cash and stock buyout
- Forum Markets forms AI compute joint venture, targets $150M in 2027 revenue
- KeyBanc's Preview of 'Biggest Potential Beats in Life Science'
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
